Short- and long-term effects of real-time continuous glucose monitoring in patients with type 2 diabetes.
about
Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the ambulatory glucose profileCurrent Trends in Continuous Glucose Monitoring.Consensus report: the current role of self-monitoring of blood glucose in non-insulin-treated type 2 diabetesThe surveillance error gridUse of Flash Glucose-Sensing Technology for 12 months as a Replacement for Blood Glucose Monitoring in Insulin-treated Type 2 Diabetes.Continuous Glucose Monitoring with Multiple Daily Insulin Treatment: Outcome Studies.Systematic review and meta-analysis of the effectiveness of continuous glucose monitoring (CGM) on glucose control in diabetes.High reported treatment satisfaction in people with type 1 diabetes switching to latest generation insulin pump regardless of previous therapy.The benefits, limitations, and cost-effectiveness of advanced technologies in the management of patients with diabetes mellitusAre Systematic Reviews and Meta-Analyses Appropriate Tools for Assessing Evolving Medical Device Technologies?Heterogeneity of responses to real-time continuous glucose monitoring (RT-CGM) in patients with type 2 diabetes and its implications for application.Minding the gaps in continuous glucose monitoring: a method to repair gaps to achieve more accurate glucometrics.The Cost-Effectiveness of Real-Time Continuous Glucose Monitoring (RT-CGM) in Type 2 DiabetesA review on B-type natriuretic peptide monitoring: assays and biosensorsA new-generation continuous glucose monitoring system: improved accuracy and reliability compared with a previous-generation system.Unblinded CGM Should Replace Blinded CGM in the Clinical Management of DiabetesThe Inclusion of Ethnic Minority Patients and the Role of Language in Telehealth Trials for Type 2 Diabetes: A Systematic ReviewEffective assessment of diabetes control using personal glucometers (CONTOURLINK, Bayer, Germany; CALLA, Wellion, Austria; LINUS, Agamatrix, USA).Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicenter, Open-Label Randomized Controlled TrialRole of continuous glucose monitoring in the management of diabetic pregnancy.Continuous glucose monitoring system: Is it really accurate, safe and clinically useful?Use of Continuous Glucose Monitoring in Youth-Onset Type 2 Diabetes.Clinical Use of Continuous Glucose Monitoring in Adults with Type 2 Diabetes.Assessing the Therapeutic Utility of Professional Continuous Glucose Monitoring in Type 2 Diabetes Across Various Therapies: A Retrospective Evaluation.Effect of treatment guidance using a retrospective continuous glucose monitoring system on glycaemic control in outpatients with type 2 diabetes mellitus: A randomized controlled trial.Improved outcomes from diabetes monitoring: the benefits of better adherence, therapy adjustments, patient education, and telemedicine supportSensing interstitial glucose to nudge active lifestyles (SIGNAL): feasibility of combining novel self-monitoring technologies for persuasive behaviour change.6(th) Annual Symposium on Self-Monitoring of Blood Glucose (SMBG) applications and beyond, April 25-27, 2013, Riga, Latvia.5(th) Annual Symposium on Self-Monitoring of Blood Glucose (SMBG) applications and beyond, May 3-5, 2012, Dublin, Ireland.Improving the clinical value and utility of CGM systems: issues and recommendations : A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group.Insulin Pump and Continuous Glucose Monitor Initiation in Hospitalized Patients with Type 2 Diabetes Mellitus.Effectiveness and acceptability of continuous glucose monitoring for type 2 Diabetes management: a narrative review.Keeping Up with the Diabetes Technology: 2016 Endocrine Society Guidelines of Insulin Pump Therapy and Continuous Glucose Monitor Management of Diabetes.Continuous Glucose Monitoring in Older Adults With Type 1 and Type 2 Diabetes Using Multiple Daily Injections of Insulin: Results From the DIAMOND Trial.Sensor and software use for the glycaemic management of insulin-treated type 1 and type 2 diabetes patients.Blood glucose control using a computer-guided glucose management system in allogeneic hematopoietic cell transplant recipients.Impact on Diabetes Self-Management and Glycemic Control of a New Color-Based SMBG Meter.A Multicenter Evaluation of the Performance and Usability of a Novel Glucose Monitoring System in Chinese Adults With Diabetes.Advances in Glucose Monitoring and Automated Insulin Delivery: Supplement to Endocrine Society Clinical Practice Guidelines
P2860
Q27687563-1DB269F8-43B1-4DB1-8193-5AF42A4F103AQ27693197-3DEE5152-A87B-443E-AA96-2BB988C45CE8Q28732681-F38653D9-C700-436E-844B-18C04FA976A4Q30301003-F1A3FBAD-2AB5-4161-8E78-1A59F6A3C37BQ30491380-AE3B97EC-CC62-4CF4-9D5E-F8D8B0FE7888Q33786220-E3F028AF-FCAE-4125-A68A-EA0D12EF37FDQ34856962-5CC302EF-0DCD-42D1-B481-34DD238811FEQ36159100-43D75C49-44E2-429D-B947-D46E633103F5Q36159119-D48A70FD-3C19-4EEB-AFB8-F4AC0CE4DE6DQ36638904-35359B48-D256-46D6-AEA2-0E267CB9AD9FQ36720426-1FC26F68-5660-4777-AFFB-08C26D06FEC2Q36954268-ECFA2D04-0689-44D2-AD9A-01D5CA21D721Q37054667-F68F8BC8-1653-44BA-95AA-9D38F50D3998Q37171880-AC0FE59A-7C4D-478D-AB21-EDDA4790EF8FQ37192444-C7521EFA-DE50-4115-9774-CABC2C9F8FEFQ37288543-A70E9CA1-AA87-4685-92F7-3F17FB8A915BQ37325229-30A1D078-C88F-4AC4-84FA-84F9A22A238EQ37433075-8D137A09-E7B2-460C-83A8-BE8AC356202FQ37639313-EB17EF01-1E38-451B-A1F4-92ACEA435388Q38053408-987ED451-7D3F-457A-A6E9-A37644B36BEEQ38213046-A1D0C733-191A-49C5-ACCB-EBFC2A756E9AQ38654692-EDB74CBB-E648-4F6B-869D-662A17C5A78AQ38679404-687DED10-27B3-4489-AD32-A322BF12E579Q38699058-C86BC84B-4EFB-4779-B668-546E09D1115EQ40232182-F1429D00-551C-4EE1-B08A-F678A05513AAQ42324880-6AA0267E-58DC-41D5-814D-A16B3B641221Q42376758-0C0EE158-BC86-4712-BAB3-7F2F15EB5B7BQ42784640-0E97CB87-4A97-43F0-811F-D7B9217DFE24Q43111019-0E1ED4FE-566B-4965-B7EC-8B6F1CC947E6Q46007893-B854CBDC-27A3-474F-A79C-2B1B701804E5Q47665596-89F14737-5ED0-40DF-8F13-A3CCB1D0C969Q49585801-67DF1ADA-12FE-471F-90A2-A50DAD91034CQ49887494-D18AE566-4B7E-4E9D-8187-72E01057C26EQ50695500-E69C6745-49BA-4FBC-BDDC-53361EC17E64Q52817224-0BAF05C4-7334-4DED-BD9A-33E63C0A9AAEQ52877010-8E522869-45AB-48BB-AE66-0F5C0B1F5CF6Q55011861-FAD7998C-BC45-40D1-BD4E-94672C7B860DQ55409284-4179D8F7-BDD7-4731-9647-9EE306054A2DQ57483085-DB97FACE-9247-4B22-BC4C-9096FC7D2546
P2860
Short- and long-term effects of real-time continuous glucose monitoring in patients with type 2 diabetes.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Short- and long-term effects o ...... patients with type 2 diabetes.
@ast
Short- and long-term effects o ...... patients with type 2 diabetes.
@en
type
label
Short- and long-term effects o ...... patients with type 2 diabetes.
@ast
Short- and long-term effects o ...... patients with type 2 diabetes.
@en
prefLabel
Short- and long-term effects o ...... patients with type 2 diabetes.
@ast
Short- and long-term effects o ...... patients with type 2 diabetes.
@en
P2093
P2860
P356
P1433
P1476
Short- and long-term effects o ...... patients with type 2 diabetes.
@en
P2093
M Susan Walker
Mary Chellappa
Nicole M Ehrhardt
Robert A Vigersky
Stephanie J Fonda
P2860
P356
10.2337/DC11-1438
P407
P577
2011-11-18T00:00:00Z